Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Complications Associated with Initial Clinical Presentation of Cystic Echinococcosis: A 20-year Cohort Analysis.

Collado-Aliaga J, Romero-Alegría Á, Alonso-Sardón M, Muro A, López-Bernus A, Velasco-Tirado V, Muñoz Bellido JL, Pardo-Lledias J, Belhassen-García M.

Am J Trop Med Hyg. 2019 Sep;101(3):628-635. doi: 10.4269/ajtmh.19-0019.

PMID:
31359859
2.

Comparative study of the prevalence of the human papilloma virus in Spanish and foreign women participating in a population screening programme in Castilla y León.

García-Villanueva S, Domínguez-Gil González M, Gayete Martínez J, Muñoz Bellido JL, Salas Valien JS, Echevarria Iturbe C, González Sagrado M, Jiménez Pérez JM, Curiel de Arcaute López A, Rojo Rello S, Eiros Bouza JM, Ortiz de Lejarazu Leonardo R.

Enferm Infecc Microbiol Clin. 2019 May;37(5):314-318. doi: 10.1016/j.eimc.2018.09.007. Epub 2018 Oct 26. English, Spanish.

PMID:
31036251
3.

Summation of peaks and L34 ribosomal protein in the presence and absence of antibiotics enables susceptibility testing using MALDI-TOF mass spectrometry in 2h from Escherichia coli-positive blood cultures.

Hernández Egido S, Luis Reboredo A, García Señán A, Gil González AB, Muñoz Bellido JL, González Buitrago JM, Sánchez-Juanes F.

Enferm Infecc Microbiol Clin. 2019 Apr;37(4):244-250. doi: 10.1016/j.eimc.2018.06.017. Epub 2018 Sep 17. English, Spanish.

PMID:
30236887
4.

Medical treatment of cystic echinococcosis: systematic review and meta-analysis.

Velasco-Tirado V, Alonso-Sardón M, Lopez-Bernus A, Romero-Alegría Á, Burguillo FJ, Muro A, Carpio-Pérez A, Muñoz Bellido JL, Pardo-Lledias J, Cordero M, Belhassen-García M.

BMC Infect Dis. 2018 Jul 5;18(1):306. doi: 10.1186/s12879-018-3201-y.

5.

Management of cystic echinococcosis in the last two decades: what have we learned?

Velasco-Tirado V, Romero-Alegria A, Pardo-Lledías J, Alonso-Sardón M, Lopez-Bernus A, Sampedro JQ, Bellvis LM, Iglesias Gomez A, Muro A, Muñoz Bellido JL, Iglesias-Iglesias M, Jimenez Lopez MF, Belhassen-García M.

Trans R Soc Trop Med Hyg. 2018 May 1;112(5):207-215. doi: 10.1093/trstmh/try050.

PMID:
29897552
6.

Mechanisms of resistance to daptomycin in Staphylococcus aureus.

Gómez Casanova N, Siller Ruiz M, Muñoz Bellido JL.

Rev Esp Quimioter. 2017 Dec;30(6):391-396. Epub 2017 Oct 25. Review.

7.

Nutritional status of children from low-income countries arriving in Spain.

Belhassen-García M, Velasco-Tirado V, Lopez-Bernus A, Muñoz Bellido JL, Muro A, Cordero M, Pardo-Lledias J.

Int Health. 2017 Sep 1;9(5):294-300. doi: 10.1093/inthealth/ihx029.

PMID:
28911127
8.

Recurrence of cystic echinococcosis in an endemic area: a retrospective study.

Velasco-Tirado V, Romero-Alegría Á, Belhassen-García M, Alonso-Sardón M, Esteban-Velasco C, López-Bernús A, Carpio-Perez A, Jimenez López MF, Muñoz Bellido JL, Muro A, Cordero-Sanchez M, Pardo-Lledias J, Muñoz-Bellvis L.

BMC Infect Dis. 2017 Jun 27;17(1):455. doi: 10.1186/s12879-017-2556-9.

9.

Fast methods of fungal and bacterial identification. MALDI-TOF mass spectrometry, chromogenic media.

Siller-Ruiz M, Hernández-Egido S, Sánchez-Juanes F, González-Buitrago JM, Muñoz-Bellido JL.

Enferm Infecc Microbiol Clin. 2017 May;35(5):303-313. doi: 10.1016/j.eimc.2016.12.010. Epub 2017 Jan 17. Review. English, Spanish.

PMID:
28108122
10.

Unusual clinical presentations of Actinotignum (Actinobaculum) schaalii infection.

Siller Ruiz M, Hernández Egido S, Calvo Sánchez N, Muñoz Bellido JL.

Enferm Infecc Microbiol Clin. 2017 Mar;35(3):197-198. doi: 10.1016/j.eimc.2016.09.006. Epub 2016 Oct 31. English, Spanish. No abstract available.

PMID:
27810121
11.

Serratia marcescens outbreak due to contaminated 2% aqueous chlorhexidine.

de Frutos M, López-Urrutia L, Domínguez-Gil M, Arias M, Muñoz-Bellido JL, Eiros JM, Ramos C.

Enferm Infecc Microbiol Clin. 2017 Dec;35(10):624-629. doi: 10.1016/j.eimc.2016.06.016. Epub 2016 Aug 3. English, Spanish.

PMID:
27495382
12.

[Historical perspective of mass spectrometry in microbiology].

Mingorance J, Regueiro B, Muñoz-Bellido JL.

Enferm Infecc Microbiol Clin. 2016 Jun;34 Suppl 2:3-7. doi: 10.1016/S0213-005X(16)30184-7. Spanish.

PMID:
27389286
13.

Screening for parasite infections in immigrant children from low-income countries.

Belhassen-García M, Pardo-Lledías J, Pérez Del Villar L, Velasco-Tirado V, Siller Ruiz M, Cordero-Sánchez M, Vicente B, Hernández Egido S, Muñoz Bellido JL, Muro A.

Enferm Infecc Microbiol Clin. 2017 Jan;35(1):27-32. doi: 10.1016/j.eimc.2016.03.007. Epub 2016 May 5.

PMID:
27156246
14.

Full coding hepatitis E virus genotype 3 genome amplification method.

Muñoz-Chimeno M, Forero JE, Echevarría JM, Muñoz-Bellido JL, Vázquez-López L, Morago L, García-Galera MC, Avellón A.

J Virol Methods. 2016 Apr;230:18-23. doi: 10.1016/j.jviromet.2016.01.004. Epub 2016 Jan 16.

PMID:
26784284
15.

Should parasitic disease be investigated in immigrant children with relative eosinophilia from tropical and sub-tropical regions?

Belhassen-García M, Pardo-Lledias J, Pérez Del Villar L, Muro A, Velasco-Tirado V, Muñoz Bellido JL, Vicente B, Blázquez de Castro A, Cordero-Sánchez M.

Paediatr Int Child Health. 2017 Feb;37(1):42-45. doi: 10.1080/20469047.2015.1109802. Epub 2016 Jan 9.

PMID:
26750778
16.

[MALDI-TOF mass spectrometry in clinical microbiology. Current situation and future perspectives].

Muñoz Bellido JL, González Buitrago JM.

Enferm Infecc Microbiol Clin. 2015 Jun-Jul;33(6):369-71. doi: 10.1016/j.eimc.2015.02.016. Epub 2015 May 7. Spanish. No abstract available.

PMID:
25958223
17.

Imported transmissible diseases in minors coming to Spain from low-income areas.

Belhassen-García M, Pérez Del Villar L, Pardo-Lledias J, Gutiérrez Zufiaurre MN, Velasco-Tirado V, Cordero-Sánchez M, Muñoz Criado S, Muñoz Bellido JL, Muro A.

Clin Microbiol Infect. 2015 Apr;21(4):370.e5-8. doi: 10.1016/j.cmi.2014.11.024. Epub 2014 Dec 3.

18.

Emergence of quinolone-resistant, topoisomerase-mutant Brucella after treatment with fluoroquinolones in a macrophage experimental infection model.

Rodríguez Tarazona E, García Rodríguez JÁ, Muñoz Bellido JL.

Enferm Infecc Microbiol Clin. 2015 Apr;33(4):248-52. doi: 10.1016/j.eimc.2014.03.010. Epub 2014 Jun 7.

PMID:
24913992
19.

Pretreatment of urine samples with SDS improves direct identification of urinary tract pathogens with matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Sánchez-Juanes F, Siller Ruiz M, Moreno Obregón F, Criado González M, Hernández Egido S, de Frutos Serna M, González-Buitrago JM, Muñoz-Bellido JL.

J Clin Microbiol. 2014 Jan;52(1):335-8. doi: 10.1128/JCM.01881-13. Epub 2013 Nov 13.

20.

Identification of fungal clinical isolates by matrix-assisted laser desorption ionization-time-of-flight mass spectrometry.

Ferreira L, Sánchez-Juanes F, Vega M, González M, García MI, Rodríguez S, González-Buitrago JM, Muñoz-Bellido JL.

Rev Esp Quimioter. 2013 Sep;26(3):193-7.

21.

Cfr-mediated linezolid resistance in methicillin-resistant Staphylococcus aureus and Staphylococcus haemolyticus associated with clinical infections in humans: two case reports.

Feßler AT, Calvo N, Gutiérrez N, Muñoz Bellido JL, Fajardo M, Garduño E, Monecke S, Ehricht R, Kadlec K, Schwarz S.

J Antimicrob Chemother. 2014 Jan;69(1):268-70. doi: 10.1093/jac/dkt331. Epub 2013 Aug 19. No abstract available.

PMID:
23960042
22.

[Is it possible to handle genitourinary system infections in our area with empirical treatment, following recommendations from recent guidelines?].

Viñuela L, de Frutos-Serna M, Asensio ML, Muñoz-Bellido JL, García-Sánchez JE.

Rev Esp Quimioter. 2013 Jun;26(2):159-61. Spanish. No abstract available.

23.

[Reliability of MALDI-TOF mass spectrometry in the identification of anaerobic bacteria].

Vega-Castaño S, Ferreira L, González-Ávila M, Sánchez-Juanes F, García-García MI, García-Sánchez JE, González-Buitrago JM, Muñoz-Bellido JL.

Enferm Infecc Microbiol Clin. 2012 Dec;30(10):597-601. doi: 10.1016/j.eimc.2012.03.002. Epub 2012 Apr 20. Spanish.

PMID:
22521278
24.

[Proteomic applications in the Clinical Microbiology laboratory].

Muñoz Bellido JL, Vega Castaño S, Ferreira L, Sánchez Juanes F, González Buitrago JM.

Enferm Infecc Microbiol Clin. 2012 Aug;30(7):383-93. doi: 10.1016/j.eimc.2011.11.003. Epub 2012 Jan 28. Review. Spanish.

PMID:
22285825
25.

Identification of Brucella by MALDI-TOF mass spectrometry. Fast and reliable identification from agar plates and blood cultures.

Ferreira L, Vega Castaño S, Sánchez-Juanes F, González-Cabrero S, Menegotto F, Orduña-Domingo A, González-Buitrago JM, Muñoz-Bellido JL.

PLoS One. 2010 Dec 6;5(12):e14235. doi: 10.1371/journal.pone.0014235.

26.

Rapid method for direct identification of bacteria in urine and blood culture samples by matrix-assisted laser desorption ionization time-of-flight mass spectrometry: intact cell vs. extraction method.

Ferreira L, Sánchez-Juanes F, Muñoz-Bellido JL, González-Buitrago JM.

Clin Microbiol Infect. 2011 Jul;17(7):1007-12. doi: 10.1111/j.1469-0691.2010.03339.x. Epub 2010 Nov 26.

27.

Microorganisms direct identification from blood culture by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Ferreira L, Sánchez-Juanes F, Porras-Guerra I, García-García MI, García-Sánchez JE, González-Buitrago JM, Muñoz-Bellido JL.

Clin Microbiol Infect. 2011 Apr;17(4):546-51. doi: 10.1111/j.1469-0691.2010.03257.x.

28.

Direct identification of urinary tract pathogens from urine samples by matrix-assisted laser desorption ionization-time of flight mass spectrometry.

Ferreira L, Sánchez-Juanes F, González-Avila M, Cembrero-Fuciños D, Herrero-Hernández A, González-Buitrago JM, Muñoz-Bellido JL.

J Clin Microbiol. 2010 Jun;48(6):2110-5. doi: 10.1128/JCM.02215-09. Epub 2010 Apr 14.

29.

Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.

Pérez-Grande R, Gutiérrez-Zufiaurre N, Muñoz-Criado S, Blázquez de Castro AM, Vázquez López L, González San Martín F, García Rodríguez JA, Muñoz Bellido JL.

Diagn Microbiol Infect Dis. 2009 May;64(1):80-2. doi: 10.1016/j.diagmicrobio.2009.01.007. Epub 2009 Mar 21.

PMID:
19304434
30.

Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.

Lázaro FG, Rodríguez-Tarazona RE, García-Rodríguez JA, Muñoz-Bellido JL.

Int J Antimicrob Agents. 2009 Sep;34(3):252-4. doi: 10.1016/j.ijantimicag.2008.12.013. Epub 2009 Feb 24.

PMID:
19243922
31.

[Problematic bacteria].

Muñoz Bellido JL.

Rev Esp Quimioter. 2008;21 Spec No 1:2-6. Review. Spanish.

32.

Prevalence of clinical isolates of Escherichia coli and Klebsiella spp. producing multiple extended-spectrum beta-lactamases.

Romero ED, Padilla TP, Hernández AH, Grande RP, Vázquez MF, García IG, García-Rodríguez JA, Muñoz Bellido JL.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):433-7. Epub 2007 Oct 29.

PMID:
17913435
33.

In vitro susceptibility of community-acquired urinary tract pathogens to commonly used antimicrobial agents in Spain: a comparative multicenter study (2002-2004).

Garcia Garcia MI, Munoz Bellido JL, Garcia Rodriguez JA; Spanish Cooperative Group for the Study of Anitimicrobial susceptibiltiy of Community Uropathogens.

J Chemother. 2007 Jun;19(3):263-70.

PMID:
17594920
34.

[Do we have adequate antimicrobials against methicillin-resistant Staphylococcus aureus?].

Muñoz Bellido JL, García-Rodríguez JA.

Rev Esp Quimioter. 2006 Dec;19(4):313-6. Spanish. No abstract available.

35.

Molecular epidemiology of drug-resistant Salmonella Typhimurium in Spain.

Delgado Ronda N, Muñoz Bellido JL, García García MI, Ibáñez Pérez R, Muñoz Criado S, Serrano Heranz R, Sáenz González MC, García Rodríguez JA.

Rev Esp Quimioter. 2006 Jun;19(2):152-60.

36.

Salmonella enterica serovar Enteritidis producing a TEM-52 beta-lactamase: first report in Spain.

Fernández Vázquez M, Muñoz Bellido JL, García García MI, García-Rodríguez JA.

Diagn Microbiol Infect Dis. 2006 Jul;55(3):245-6. Epub 2006 Apr 19.

PMID:
16626913
37.

[Prevalence of anti-Chlamydophila pneumoniae antibodies in patients with intrinsic asthma].

Rodríguez Polo JA, Muñoz FJ, Muñoz Bellido JL, García Rodríguez JA.

Rev Esp Quimioter. 2005 Jun;18(2):146-8. Spanish.

38.

[Colistimethate: an old antibiotic revived by new scientific evidence].

Muñoz Bellido JL, García-Rodríguez JA.

Rev Esp Quimioter. 2005 Mar;18(1):11-3. Spanish. No abstract available.

39.

Salmonella enterica serovar infantis producing a CTX-M-9 beta-lactamase.

Valverde Romero E, Parras Padilla T, García García MI, Delgado Ronda N, Herrero A, Muñoz Bellido JL, García Rodríguez JA.

Antimicrob Agents Chemother. 2005 May;49(5):2142-3. No abstract available.

40.

[Wide-spectrum beta-lactamases: are they a serious problem today in Spain?].

Muñoz Bellido JL.

Rev Esp Quimioter. 2004 Dec;17(4):314-6. Spanish. No abstract available.

41.

Topoisomerases mutations and fluoroquinolone resistance in Stenotrophomonas maltophilia.

Trigo Daporta M, Muñoz Bellido JL, García-Rodríguez JA.

Int J Antimicrob Agents. 2004 Nov;24(5):520-1. No abstract available.

PMID:
15519490
42.

[Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women].

Gutiérrez-Zufiaurre N, Sánchez-Hernández J, Muñoz S, Marín R, Delgado N, Sáenz MC, Muñoz-Bellido JL, García-Rodríguez JA.

Enferm Infecc Microbiol Clin. 2004 Nov;22(9):512-6. Spanish.

PMID:
15511391
43.

In vitro activity of older and newer fluoroquinolones against efflux-mediated high-level ciprofloxacin-resistant Streptococcus pneumoniae.

Daporta MT, Muñoz Bellido JL, Guirao GY, Hernández MS, García-Rodríguez JA.

Int J Antimicrob Agents. 2004 Aug;24(2):185-7.

PMID:
15288320
44.

[Antimicrobial drug resistance in non-typhi Salmonellae in Castilla y Leon].

Delgado Ronda M, Munoz Bellido JL, Ibanez Perez R, Garcia Garcia MI, Serrano Heranz R, Munoz Criado S, Garcia Rodriguez JA.

Rev Esp Quimioter. 2004 Mar;17(1):29-36. Spanish.

45.

[Do ketolides have real advantages over macrolides?].

Muñoz Bellido JL, García-Rodríguez JA.

Rev Esp Quimioter. 2003 Sep;16(3):273-6. Spanish. No abstract available.

46.

In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.

Sánchez Hernández J, Mora Peris B, Yagüe Guirao G, Gutiérrez Zufiaurre N, Muñoz Bellido JL, Segovia Hernández M, García Rodríguez JA.

Int J Antimicrob Agents. 2003 Nov;22(5):492-6.

PMID:
14602367
47.

[Fusidic Acid].

García-Rodríguez JA, Gutiérrez Zufiaurre N, Munoz Bellido JL.

Rev Esp Quimioter. 2003 Jun;16(2):161-71. Review. Spanish. No abstract available.

48.

[In vitro activity of moxifloxacin against respiratory pathogens in Latin America].

López H, Sader H, Amábile C, Pedreira W, Muñoz Bellido JL, García Rodríguez JA; Grupo MSP-LA.

Rev Esp Quimioter. 2002 Dec;15(4):325-34. Spanish.

49.

In vitro activity of linezolid, synercid and telithromycin against genetically defined high level fluoroquinolone-resistant methicillin-resistant Staphylococcus aureus.

Muñoz Bellido JL, Gutiérrez Zufiaurre MN, Sánchez Hernández FJ, Yagüe Guirao G, Segovia Hernández M, García-Rodríguez JA.

Int J Antimicrob Agents. 2002 Jul;20(1):61-4.

PMID:
12127713
50.

Oral cephalosporins in uncomplicated urinary tract infections.

García-Rodríguez JA, Muñoz Bellido JL.

Clin Microbiol Infect. 2000;6 Suppl 3:73-5. Review. No abstract available.

Supplemental Content

Loading ...
Support Center